Abstract
REPORT HIGHLIGHTS
The global market for personalized medicine technology is projected to be
$14.4 billion in 2009 and is expected to reach $29.2 billion in 2014, for a
compound annual growth rate (CAGR) of 15.2% Pharmacogenomics is a major
revenue generating market, contributing about 28.7% to the total personalized
medicine market in 2009, at $4.1 billion; this should reach $9.5 billion in
2014, for a CAGR of 18% The point-of-care market has the second largest share
of the market, at $2.7 billion in 2009. This is expected to increase to $5.1
billion in 2014, for a CAGR of 18%.
STUDY GOALS AND OBJECTIVES
- To measure the personalized medicine market, which has experienced high
growth year to year.
- To analyze the current personalized medicine business model and to
evaluate the commercial use of the personalized medicine technology platform.
- To analyze individual submarkets for personalized medicine in terms of
technology, products, services, application areas and geography.
- To estimate the growth rate of all the submarkets based on various factors.
- To analyze and forecast the market data for each subsegment for the next 5
years.
- To define and identify the high growth markets among the subsegments of
the personalized medicine market.
- To strategically discuss the trends and market opportunities for the
various stakeholders in identifying the focus areas within the market.
- To strategically analyze the competitive landscape and the participation
of all the top companies in the market.
REASONS FOR DOING THE STUDY
Personalized diagnosis and treatment - or personalized medicine - is the
most recent trend in the multibillion - dollar molecular diagnostics industry.
Pharmaceutical and biotechnology companies are increasingly turning to
personalized medicine in order to improve the drug development process and
also to speed up the approval of new drugs.
According to the industry consensus, personalized medicine will not only form
an integral part of mainstream medicine in the next few years, it is also
expected to reform the development, testing, marketing and prescription of
drugs during the next decade. The big pharmaceutical companies eventually will
change their tried - and - tested blockbuster business model to more -
targeted and effective healthcare solutions.
Several diagnostic and life - science companies have yet to tap the complete
personalized medicine market, which is experiencing rapid growth all over the
world. A detailed study of the different subsegments within personalized
medicine is required for existing and new players to develop new strategies to
harness the expanding market. This research report will address this need by
analyzing market trends, new and available opportunities and the current
competitive landscape in the personalized medicine market.
SCOPE OF REPORT
The personalized medicine market is segmented according to products, services,
technology, applications and geography. Each section will provide market data,
market drivers, trends and opportunities, top - selling products and the
profiles of key market players. Along with the company profiles, the report
will feature market tables to provide complete insight on the market. All
market tables are categorized according to products, services, technologies,
applications and geography. The report also highlights the strategic issues
involved in tapping the personalized medicine market, which is reporting
double - digit growth year - on - year.
INTENDED AUDIENCE
The intended audience includes all the stakeholders (except end - users) of
the personalized medicine market: Equipment manufacturers, specialized
technology providers, pharmaceutical companies, biotechnology companies and
diagnostic companies and physicians.
This report provides all the necessary information for all industry
participants to understand the market scenario and develop marketing
strategies based on the opportunities highlighted here. The market data and
forecasts made up to the year 2014 explain the demand for products and
services.
INFORMATION SOURCES AND METHODOLOGY
The market data will consist of aggregate revenues generated from all
submarkets within the personalized medicine market. We have analyzed existing
and new technologies in the personalized medicine market, and studied the new
products introduced in these categories. The report examines all the
application areas and also identifies the unexplored markets. We have
researched all technology patents over the last 5 years. We have also analyzed
the key market developments of the top companies, and provided profiles for
each of these players. Information has been collected through paid and unpaid
secondary sources; and primary research was conducted to get a more in - depth
understanding of the facts and facets of the industry.
| 
View Cart
